ALDX.OQ - Aldeyra Therapeutics Inc
Aldeyra Therapeutics Inc
Laidlaw & Company

Laidlaw: ALDX: A third CRL on reproxalap in DED NDA with the FDA Type A meeting later in 2Q26

公司
ALDX.OQ
日期
2026-03-17
分析师
Mr. Yale I. Jen, PHD
页数
6
需要登录
请登录后购买研报或生成音频内容。